FDG PET/CT in a Case of Isolated Gastric Metastasis From Pancreatic Ductal Adenocarcinoma

被引:0
|
作者
Ji, Xia [1 ,4 ]
Dong, Aisheng [2 ]
Wang, Yang [3 ]
机构
[1] Jiaxing Univ, Affiliated Hosp 2, Dept Gastroenterol, Jiaxing 314001, Zhejiang Provin, Peoples R China
[2] Naval Med Univ, Changhai Hosp, Dept Nucl Med, Shanghai, Peoples R China
[3] Tongji Univ, Dept Pathol, Shanghai Peoples Hosp 4, Sch Med, Shanghai, Peoples R China
[4] Jiaxing Univ, Affiliated Hosp 2, Dept Gastroenterol, 1518 North Huancheng Rd, Jiaxing 314000, Zhejiang Provin, Peoples R China
关键词
pancreatic cancer; stomach; metastasis; PET/CT; CT; CARCINOMA; STOMACH; TUMORS;
D O I
10.1097/RLU.0000000000005099
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Hematogenous gastric metastasis from pancreatic cancer is extremely rare. We describe FDG PET/CT findings in a case of isolated hematogenous gastric metastasis from pancreatic cancer with significantly elevated serum carbohydrate antigen 19-9 level. The gastric metastasis showed intense focal FDG uptake mimicking a primary tumor. The elevation of serum carbohydrate antigen 19-9 level may be useful as an aid in the differential diagnosis.
引用
收藏
页码:377 / 378
页数:2
相关论文
共 50 条
  • [31] Comparison of F-18-FDG PET/CT findings between pancreatic solid pseudopapillary tumor and pancreatic ductal adenocarcinoma
    Kim, Yong-il
    Kim, Seok-ki
    Paeng, Jin Chul
    Lee, Ho-Young
    EUROPEAN JOURNAL OF RADIOLOGY, 2014, 83 (01) : 231 - 235
  • [32] FDG PET/CT in Isolated Spermatic Cord Metastasis From Colon Cancer
    Ji, Xia
    Dong, Aisheng
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (01) : E81 - E82
  • [33] Radiomics analysis for the differentiation of autoimmune pancreatitis and pancreatic ductal adenocarcinoma in 18F-FDG PET/CT
    Zhang, Yuquan
    Cheng, Chao
    Liu, Zhaobang
    Wang, Lei
    Pan, Guixia
    Sun, Gaofeng
    Chang, Yan
    Zuo, Changjing
    Yang, Xiaodong
    MEDICAL PHYSICS, 2019, 46 (10) : 4520 - 4530
  • [34] Pancreatic ductal adenocarcinoma with metastasis in soft tissue: A case report
    Costa Braga, A.
    Oliveira, P.
    VIRCHOWS ARCHIV, 2014, 465 : S59 - S59
  • [35] FDG PET/CT in a Case of Diffuse Esophageal Adenocarcinoma
    Zhang, Jian
    Yu, Zhongfei
    Li, Zhi
    Dong, Aisheng
    Zhu, Yuzhao
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (05) : 462 - 463
  • [36] FDG PET/CT in a Case of Pure Ductal Adenocarcinoma of the Prostate With Osteolytic Metastases and Normal PSA Level
    Dong, Aisheng
    Lin, Xumiao
    Bai, Yushu
    Yang, Bo
    Xu, Shengming
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (07) : 640 - 642
  • [37] Synchronous gastric adenocarcinoma and pancreatic ductal adenocarcinoma
    Muroni, Mirko
    D'Angelo, Francesco
    Pezzatini, Massimo
    Sebastiani, Simone
    Noto, Samantha
    Pilozzi, Emanuela
    Ramacciato, Giovanni
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2010, 9 (01) : 97 - 99
  • [38] Synchronous gastric adenocarcinoma and pancreatic ductal adenocarcinoma
    Mirko Muroni
    Francesco D'Angelo
    Massimo Pezzatini
    Simone Sebastiani
    Samantha Noto
    Emanuela Pilozzi
    Giovanni Ramacciato
    Hepatobiliary&PancreaticDiseasesInternational, 2010, 9 (01) : 97 - 99
  • [39] A rare case of esophageal metastasis from pancreatic ductal adenocarcinoma: a case report and literature review
    Rosati, Lauren M.
    Kummerlowe, Megan N.
    Poling, Justin
    Hacker-Prietz, Amy
    Narang, Amol K.
    Shin, Eun J.
    Le, Dung T.
    Fishman, Elliot K.
    Hruban, Ralph H.
    Yang, Stephen C.
    Weiss, Matthew J.
    Herman, Joseph M.
    ONCOTARGET, 2017, 8 (59) : 100942 - 100950
  • [40] Prognostic Significance of 18F-FDG PET/CT and Tumor Metabolic Changes in Patients With Pancreatic Ductal Adenocarcinoma
    Shimomura, Ayaka
    Oshima, Minoru
    Suto, Hironobu
    Matsukawa, Hiroyuki
    Kondo, Akihiro
    Ando, Yasuhisa
    Kishino, Takayoshi
    Kumamoto, Kensuke
    Sato, Kiyotoshi
    Sugimoto, Masahiro
    Nagao, Mina
    Miyatake, Nobuyuki
    Norikane, Takashi
    Soga, Tomoyoshi
    Okano, Keiichi
    ANTICANCER RESEARCH, 2024, 44 (08) : 3321 - 3330